Novo Nordisk
NVO
#21
Rank
A$681.06 B
Marketcap
$156.71
Share price
-2.81%
Change (1 day)
-0.70%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Cash on Hand

Cash on Hand as of September 2024 : A$17.18 Billion

According to Novo Nordisk's latest financial reports the company has A$17.18 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novo Nordisk - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$6.57 B31.73%
2022-12-31A$4.98 B35.86%
2021-12-31A$3.67 B33.89%
2020-12-31A$2.74 B-17.25%
2019-12-31A$3.31 B-2.56%
2018-12-31A$3.40 B-12.63%
2017-12-31A$3.89 B-4.25%
2016-12-31A$4.06 B-1.24%
2015-12-31A$4.11 B29.7%
2014-12-31A$3.17 B5.69%
2013-12-31A$3.00 B9.29%
2012-12-31A$2.74 B-7.59%
2011-12-31A$2.97 B5.45%
2010-12-31A$2.82 B2.53%
2009-12-31A$2.75 B1.46%
2008-12-31A$2.71 B63.99%
2007-12-31A$1.65 B44.03%
2006-12-31A$1.14 B5.7%
2005-12-31A$1.08 B15.7%
2004-12-31A$0.93 B33.13%
2003-12-31A$0.70 B58.66%
2002-12-31A$0.44 B-48.28%
2001-12-31A$0.85 B161.93%
2000-12-31A$0.32 B17.88%
1999-12-31A$0.27 B48.83%
1998-12-31A$0.18 B-24.56%
1997-12-31A$0.24 B49.84%
1996-12-31A$0.16 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$15.24 B-11.28%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.38 B-68.63%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.39 B-27.84%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.15 B-35.06%๐Ÿ‡ซ๐Ÿ‡ท France